iPSC‐ and mesenchymoangioblast‐derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid-Reference-Cited by-同舟云学术

iPSC‐ and mesenchymoangioblast‐derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid

Published:2019-02-15 Issue:5 Volume:33 Page:6402-6411
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Royce Simon G.¹²³,Mao Weiyi¹²,Lim Rebecca⁴,Kelly Kilian⁵,Samuel Chrishan S.¹²⁶

Affiliation:

1. Monash Biomedicine Discovery Institute Monash University Clayton Victoria Australia

2. Department of Pharmacology Monash University Clayton Victoria Australia

3. Central Clinical School Monash University Clayton Victoria Australia

4. The Ritchie Centre Hudson Institute of Medical Research Department of Obstetrics and Gynecology Monash University Clayton Victoria Australia

5. Cynata Therapeutics Carlton Victoria Australia

6. Department of Biochemistry and Molecular Biology The University of Melbourne Parkville Victoria Australia

Funder

National Health and Medical Research Council

Intelligence Community Postdoctoral Research Fellowship Program

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802307R

Reference34 articles.

1. Asthma and COPD: differences and similarities

2. The global burden of asthma: executive summary of the GINA Dissemination Committee Report

3. Pathogenesis of Asthma

4. Rethinking the Pathogenesis of Asthma

5. A new look at the pathogenesis of asthma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness;Biomedicine & Pharmacotherapy;2024-09

2. Human macrophage migration inhibitory factor potentiates mesenchymal stromal cell efficacy in a clinically relevant model of allergic asthma;Molecular Therapy;2023-11

3. Mesenchymal Stem/Stromal Cells in Asthma Therapy: Mechanisms and Strategies for Enhancement;Cell Transplantation;2023-01

4. Effects of human adipose tissue- and bone marrow-derived mesenchymal stem cells on airway inflammation and remodeling in a murine model of chronic asthma;Scientific Reports;2022-07-14

5. Intratracheal administration of mesenchymal stem cells modulates lung macrophage polarization and exerts anti-asthmatic effects;Scientific Reports;2022-07-11